Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indrayani Biotech has informed that, in accordance with Regulation 33(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, meeting of the Board of Directors will be held on Wednesday, 14th June, 2023 to consider and approve the following: The Audited Financial Results (Standalone and Consolidated) for the Quarter and year ended 31st March, 2023 along with the Audit report of Statutory Auditor and any other business with the permission of the Chair.
The above information is a part of company’s filings submitted to BSE.
